Form D · Pharmaceuticals
IntelGenx Technologies Corp.
Ville Saint Laurent, A8 · CIK 0001098880
Offering snapshot reported Mar 28, 2023 · SEC filing
- Reported sold
- $763K Offering amount: $2M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Mar 21, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 28, 2023 | Initial | $763,000 | No comparison | 26 | SEC filing |
| Sep 10, 2021 | Amendment | $2,101,000 | $0vs Aug 17, 2021 | 34 | SEC filing |
| Aug 17, 2021 | Initial | $2,101,000 | No comparison | Not reported | SEC filing |
| Oct 27, 2020 | Initial | $1,762,000 | No comparison | 53 | SEC filing |
| May 17, 2018 | Initial | $2,480,000 | No comparison | 38 | SEC filing |
| Jun 29, 2011 | Amendment | $1,730,298 | $0vs Jun 28, 2011 | 20 | SEC filing |
| Jun 28, 2011 | Initial | $1,730,298 | No comparison | 20 | SEC filing |
| Jun 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $53.4K
- Finders' fees
- $0
- Form D file number
- 021-477175
Issuer discontinued the offering.
10% notes convertible to common stock at $0.20 per share.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Anthony J. Cantone | 1066139 | Cantone Research Inc. · CRD 26314 |
| John Cantone | 5190538 | Cantone Research Inc. · CRD 26314 |
Source: Form D, filed Mar 28, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Bernard Boudreau | Director |
| Andre Godin | Executive |
| Rajiv Khosla | Director |
| John Marinucci | Director |
| Clemens Mayr | Director |
| Bernd J. Melchers | Director |
| Mark Nawacki | Director |
| Srinivas Rao | Director |
| Paul A. Simmons | Executive |
| Frank Stegert | Director |
| Ian Troup | Director |
| Monika Trzcinska | Director |
| Ingrid Zerbe | Executive |
| Horst G. Zerbe | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6420 Abrams
Ville Saint Laurent, A8, H4S 1Y2
Ville Saint Laurent, A8, H4S 1Y2